March 05, 2018
Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial
In Leishmania infantum–endemic countries, controlling infection within dogs, the domestic reservoir, is critical to public health. There is a need for safe vaccines that prevent canine progression with disease and transmission to others. Protective vaccination against Leishmania requires mounting a strong, inflammatory, Type 1 response. Three commercially available canine vaccines on the global veterinary market use saponin or inflammatory antigen components (Letifend) as a strong pro-inflammatory adjuvant. There is very little information detailing safety of saponin as an adjuvant in field trials. Safety analyses for the use of vaccine as an immunotherapeutic in asymptomatically infected animals are completely lacking. Leishmania infantum, the causative agent of canine leishmaniasis, is enzootic within U.S. hunting hounds. We assessed the safety of LeishTec® after use in dogs from two different clinical states: 1) without clinical signs and tested negative on polymerase chain reaction and serology or 2) without clinical signs and positive for at least one Leishmania diagnostic test. Vaccine safety was assessed after all three vaccinations to quantify the number and severity of adverse events. Vaccinated animals had an adverse event rate of 3.09%, whereas placebo animals had 0.68%. Receiving vaccine was correlated with the occurrence of mild, site-specific, reactions. Occurrence of severe adverse events was not associated with having received vaccine. Infected, asymptomatic animals did not have a higher rate of adverse events. Use of vaccination is, therefore, likely to be safe in infected, asymptomatic animals.
Read the full article in The American of Tropical Medicine and Hygiene.
More from CNAS
-
Drones, Missiles, and the U.S. Munitions Shortage
Reports
Executive Summary Drones have exploded in popularity since Russia’s full-scale invasion of Ukraine in 2022. There is a growing view that inexpensive drones—“affordable mass”—a...
By Philip Sheers & Stacie Pettyjohn
-
Rethink... Warfare
Podcast
Stacie Pettyjohn, director of the Defense Program at the Center for a New American Security, joins BBC Sounds - Rethink to discuss how recent conflicts have changed the shape ...
By Stacie Pettyjohn
-
A Body Blow? The War on Iran and U.S. Military Readiness
Podcast
The war against Iran is putting new strains on U.S. military readiness by consuming munitions and missile defense interceptors, as well as through extended deployments, sustai...
By Stacie Pettyjohn
-
Iran Blockade Costs Are Draining America’s Global Military Power
Video
As US President Donald Trump tries to force Iran into submission, a naval blockade is proving to be his tool of choice. But the operation is stretching the American military t...
By Becca Wasser
